This pipeline computes the correlation between cancer subtypes identified by different molecular patterns and selected clinical features.
Testing the association between subtypes identified by 10 different clustering approaches and 14 clinical features across 331 patients, 31 significant findings detected with P value < 0.05.
-
CNMF clustering analysis on array-based mRNA expression data identified 4 subtypes that correlate to 'TOBACCOSMOKINGHISTORYINDICATOR'.
-
Consensus hierarchical clustering analysis on array-based mRNA expression data identified 3 subtypes that do not correlate to any clinical features.
-
3 subtypes identified in current cancer cohort by 'CN CNMF'. These subtypes correlate to 'AGE', 'STOPPEDSMOKINGYEAR', 'TOBACCOSMOKINGHISTORYINDICATOR', and 'YEAROFTOBACCOSMOKINGONSET'.
-
3 subtypes identified in current cancer cohort by 'METHLYATION CNMF'. These subtypes correlate to 'Time to Death', 'AGE', and 'TOBACCOSMOKINGHISTORYINDICATOR'.
-
CNMF clustering analysis on RPPA data identified 3 subtypes that correlate to 'AGE', 'KARNOFSKY.PERFORMANCE.SCORE', 'STOPPEDSMOKINGYEAR', 'TOBACCOSMOKINGHISTORYINDICATOR', and 'YEAROFTOBACCOSMOKINGONSET'.
-
Consensus hierarchical clustering analysis on RPPA data identified 4 subtypes that correlate to 'AGE', 'HISTOLOGICAL.TYPE', 'STOPPEDSMOKINGYEAR', 'TOBACCOSMOKINGHISTORYINDICATOR', and 'YEAROFTOBACCOSMOKINGONSET'.
-
CNMF clustering analysis on sequencing-based mRNA expression data identified 5 subtypes that correlate to 'Time to Death', 'AGE', 'GENDER', 'PATHOLOGY.N', and 'TOBACCOSMOKINGHISTORYINDICATOR'.
-
Consensus hierarchical clustering analysis on sequencing-based mRNA expression data identified 3 subtypes that correlate to 'Time to Death', 'GENDER', 'STOPPEDSMOKINGYEAR', and 'TOBACCOSMOKINGHISTORYINDICATOR'.
-
CNMF clustering analysis on sequencing-based miR expression data identified 3 subtypes that correlate to 'TOBACCOSMOKINGHISTORYINDICATOR'.
-
Consensus hierarchical clustering analysis on sequencing-based miR expression data identified 4 subtypes that correlate to 'GENDER', 'STOPPEDSMOKINGYEAR', and 'TOBACCOSMOKINGHISTORYINDICATOR'.
Table 1. Get Full Table Overview of the association between subtypes identified by 10 different clustering approaches and 14 clinical features. Shown in the table are P values from statistical tests. Thresholded by P value < 0.05, 31 significant findings detected.
Clinical Features |
Statistical Tests |
mRNA CNMF subtypes |
mRNA cHierClus subtypes |
CN CNMF |
METHLYATION CNMF |
RPPA CNMF subtypes |
RPPA cHierClus subtypes |
RNAseq CNMF subtypes |
RNAseq cHierClus subtypes |
MIRseq CNMF subtypes |
MIRseq cHierClus subtypes |
Time to Death | logrank test | 0.821 | 0.914 | 0.93 | 0.0209 | 0.0585 | 0.087 | 0.000633 | 0.0136 | 0.5 | 0.267 |
AGE | ANOVA | 0.477 | 0.557 | 0.000119 | 0.0395 | 0.0146 | 0.00448 | 0.00176 | 0.156 | 0.637 | 0.233 |
GENDER | Fisher's exact test | 0.272 | 0.383 | 0.103 | 0.0767 | 0.231 | 0.147 | 0.0417 | 0.00131 | 0.791 | 0.0192 |
KARNOFSKY PERFORMANCE SCORE | ANOVA | 0.392 | 0.764 | 0.0491 | 0.302 | 0.431 | 0.704 | 0.933 | 0.952 | ||
HISTOLOGICAL TYPE | Chi-square test | 0.3 | 0.274 | 0.272 | 0.0709 | 0.166 | 0.00633 | 0.0922 | 0.112 | 0.087 | 0.442 |
PATHOLOGY T | Chi-square test | 0.489 | 0.479 | 0.304 | 0.55 | 0.184 | 0.658 | 0.297 | 0.526 | 0.456 | 0.843 |
PATHOLOGY N | Chi-square test | 0.572 | 0.651 | 0.732 | 0.391 | 0.439 | 0.481 | 0.00287 | 0.0711 | 0.961 | 0.129 |
PATHOLOGICSPREAD(M) | Chi-square test | 0.504 | 1 | 0.794 | 0.687 | 0.851 | 0.761 | 0.85 | 0.791 | 0.275 | 0.557 |
TUMOR STAGE | Chi-square test | 0.147 | 0.274 | 0.118 | 0.716 | 0.903 | 0.98 | 0.165 | 0.14 | 0.738 | 0.35 |
RADIATIONS RADIATION REGIMENINDICATION | Fisher's exact test | 1 | 1 | 0.341 | 0.137 | 0.893 | 0.373 | 0.745 | 0.677 | 0.784 | 0.829 |
NUMBERPACKYEARSSMOKED | ANOVA | 0.448 | 0.357 | 0.167 | 0.374 | 0.479 | 0.244 | 0.0871 | 0.269 | 0.533 | 0.485 |
STOPPEDSMOKINGYEAR | ANOVA | 0.224 | 0.397 | 0.0242 | 0.357 | 0.00862 | 0.0126 | 0.0716 | 0.0194 | 0.144 | 0.0357 |
TOBACCOSMOKINGHISTORYINDICATOR | Chi-square test | 0.0492 | 0.184 | 0.000111 | 0.000775 | 0.000452 | 0.000189 | 0.00141 | 1.78e-05 | 0.00543 | 0.000253 |
YEAROFTOBACCOSMOKINGONSET | ANOVA | 0.616 | 0.68 | 0.0354 | 0.516 | 0.0307 | 0.0134 | 0.309 | 0.216 | 0.126 | 0.124 |
Table S1. Get Full Table Description of clustering approach #1: 'mRNA CNMF subtypes'
Cluster Labels | 1 | 2 | 3 | 4 |
---|---|---|---|---|
Number of samples | 5 | 9 | 12 | 6 |
P value = 0.821 (logrank test)
Table S2. Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #1: 'Time to Death'
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 31 | 4 | 0.5 - 56.8 (8.3) |
subtype1 | 4 | 0 | 6.0 - 48.6 (9.7) |
subtype2 | 9 | 1 | 4.0 - 56.8 (8.3) |
subtype3 | 12 | 1 | 0.5 - 37.0 (3.3) |
subtype4 | 6 | 2 | 2.0 - 45.2 (30.9) |
Figure S1. Get High-res Image Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #1: 'Time to Death'
![](D1V1.png)
P value = 0.477 (ANOVA)
Table S3. Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 30 | 65.7 (10.8) |
subtype1 | 4 | 58.5 (15.5) |
subtype2 | 9 | 65.0 (9.1) |
subtype3 | 12 | 67.1 (11.1) |
subtype4 | 5 | 69.4 (9.0) |
Figure S2. Get High-res Image Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #2: 'AGE'
![](D1V2.png)
P value = 0.272 (Fisher's exact test)
Table S4. Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #3: 'GENDER'
nPatients | FEMALE | MALE |
---|---|---|
ALL | 18 | 14 |
subtype1 | 3 | 2 |
subtype2 | 3 | 6 |
subtype3 | 9 | 3 |
subtype4 | 3 | 3 |
Figure S3. Get High-res Image Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #3: 'GENDER'
![](D1V3.png)
P value = 0.3 (Chi-square test)
Table S5. Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
nPatients | LUNG ADENOCARCINOMA MIXED SUBTYPE | LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS) | LUNG CLEAR CELL ADENOCARCINOMA |
---|---|---|---|
ALL | 1 | 30 | 1 |
subtype1 | 0 | 4 | 1 |
subtype2 | 0 | 9 | 0 |
subtype3 | 1 | 11 | 0 |
subtype4 | 0 | 6 | 0 |
Figure S4. Get High-res Image Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
![](D1V5.png)
P value = 0.489 (Chi-square test)
Table S6. Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #6: 'PATHOLOGY.T'
nPatients | T1 | T2 | T3 |
---|---|---|---|
ALL | 12 | 19 | 1 |
subtype1 | 3 | 2 | 0 |
subtype2 | 4 | 4 | 1 |
subtype3 | 4 | 8 | 0 |
subtype4 | 1 | 5 | 0 |
Figure S5. Get High-res Image Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #6: 'PATHOLOGY.T'
![](D1V6.png)
P value = 0.572 (Chi-square test)
Table S7. Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #7: 'PATHOLOGY.N'
nPatients | N0 | N1 | N2+N3 |
---|---|---|---|
ALL | 23 | 4 | 4 |
subtype1 | 3 | 1 | 1 |
subtype2 | 8 | 1 | 0 |
subtype3 | 9 | 1 | 1 |
subtype4 | 3 | 1 | 2 |
Figure S6. Get High-res Image Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #7: 'PATHOLOGY.N'
![](D1V7.png)
P value = 0.504 (Fisher's exact test)
Table S8. Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
nPatients | M0 | M1 |
---|---|---|
ALL | 30 | 2 |
subtype1 | 4 | 1 |
subtype2 | 9 | 0 |
subtype3 | 11 | 1 |
subtype4 | 6 | 0 |
Figure S7. Get High-res Image Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
![](D1V8.png)
P value = 0.147 (Chi-square test)
Table S9. Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #9: 'TUMOR.STAGE'
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 23 | 4 | 3 | 2 |
subtype1 | 3 | 1 | 0 | 1 |
subtype2 | 8 | 0 | 1 | 0 |
subtype3 | 10 | 1 | 0 | 1 |
subtype4 | 2 | 2 | 2 | 0 |
Figure S8. Get High-res Image Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #9: 'TUMOR.STAGE'
![](D1V9.png)
P value = 1 (Fisher's exact test)
Table S10. Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
nPatients | NO | YES |
---|---|---|
ALL | 1 | 31 |
subtype1 | 0 | 5 |
subtype2 | 0 | 9 |
subtype3 | 1 | 11 |
subtype4 | 0 | 6 |
Figure S9. Get High-res Image Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
![](D1V10.png)
P value = 0.448 (ANOVA)
Table S11. Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 20 | 41.1 (15.0) |
subtype1 | 2 | 29.0 (12.7) |
subtype2 | 9 | 47.0 (15.5) |
subtype3 | 6 | 37.0 (13.1) |
subtype4 | 3 | 40.0 (17.3) |
Figure S10. Get High-res Image Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
![](D1V11.png)
P value = 0.224 (ANOVA)
Table S12. Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 15 | 1998.4 (10.1) |
subtype1 | 2 | 2001.5 (12.0) |
subtype2 | 6 | 2002.5 (10.9) |
subtype3 | 5 | 1994.2 (10.1) |
subtype4 | 2 | 1993.5 (4.9) |
Figure S11. Get High-res Image Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
![](D1V12.png)
P value = 0.0492 (Chi-square test)
Table S13. Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
nPatients | CURRENT REFORMED SMOKER FOR < OR = 15 YEARS | CURRENT REFORMED SMOKER FOR > 15 YEARS | CURRENT SMOKER | LIFELONG NON-SMOKER |
---|---|---|---|---|
ALL | 12 | 10 | 5 | 5 |
subtype1 | 3 | 0 | 0 | 2 |
subtype2 | 5 | 3 | 1 | 0 |
subtype3 | 2 | 6 | 1 | 3 |
subtype4 | 2 | 1 | 3 | 0 |
Figure S12. Get High-res Image Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
![](D1V13.png)
P value = 0.616 (ANOVA)
Table S14. Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 19 | 1968.5 (11.4) |
subtype1 | 2 | 1977.0 (18.4) |
subtype2 | 6 | 1971.2 (14.2) |
subtype3 | 6 | 1965.8 (8.2) |
subtype4 | 5 | 1965.2 (9.8) |
Figure S13. Get High-res Image Clustering Approach #1: 'mRNA CNMF subtypes' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
![](D1V14.png)
Table S15. Get Full Table Description of clustering approach #2: 'mRNA cHierClus subtypes'
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 7 | 13 | 12 |
P value = 0.914 (logrank test)
Table S16. Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #1: 'Time to Death'
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 31 | 4 | 0.5 - 56.8 (8.3) |
subtype1 | 7 | 2 | 2.0 - 48.6 (38.7) |
subtype2 | 13 | 1 | 0.5 - 37.0 (3.4) |
subtype3 | 11 | 1 | 4.0 - 56.8 (8.1) |
Figure S14. Get High-res Image Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #1: 'Time to Death'
![](D2V1.png)
P value = 0.557 (ANOVA)
Table S17. Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 30 | 65.7 (10.8) |
subtype1 | 5 | 69.4 (9.0) |
subtype2 | 13 | 66.5 (10.9) |
subtype3 | 12 | 63.3 (11.6) |
Figure S15. Get High-res Image Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #2: 'AGE'
![](D2V2.png)
P value = 0.383 (Fisher's exact test)
Table S18. Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #3: 'GENDER'
nPatients | FEMALE | MALE |
---|---|---|
ALL | 18 | 14 |
subtype1 | 4 | 3 |
subtype2 | 9 | 4 |
subtype3 | 5 | 7 |
Figure S16. Get High-res Image Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #3: 'GENDER'
![](D2V3.png)
P value = 0.274 (Chi-square test)
Table S19. Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
nPatients | LUNG ADENOCARCINOMA MIXED SUBTYPE | LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS) | LUNG CLEAR CELL ADENOCARCINOMA |
---|---|---|---|
ALL | 1 | 30 | 1 |
subtype1 | 0 | 6 | 1 |
subtype2 | 1 | 12 | 0 |
subtype3 | 0 | 12 | 0 |
Figure S17. Get High-res Image Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
![](D2V5.png)
P value = 0.479 (Chi-square test)
Table S20. Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #6: 'PATHOLOGY.T'
nPatients | T1 | T2 | T3 |
---|---|---|---|
ALL | 12 | 19 | 1 |
subtype1 | 2 | 5 | 0 |
subtype2 | 4 | 9 | 0 |
subtype3 | 6 | 5 | 1 |
Figure S18. Get High-res Image Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #6: 'PATHOLOGY.T'
![](D2V6.png)
P value = 0.651 (Chi-square test)
Table S21. Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #7: 'PATHOLOGY.N'
nPatients | N0 | N1 | N2+N3 |
---|---|---|---|
ALL | 23 | 4 | 4 |
subtype1 | 4 | 1 | 2 |
subtype2 | 10 | 1 | 1 |
subtype3 | 9 | 2 | 1 |
Figure S19. Get High-res Image Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #7: 'PATHOLOGY.N'
![](D2V7.png)
P value = 1 (Fisher's exact test)
Table S22. Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
nPatients | M0 | M1 |
---|---|---|
ALL | 30 | 2 |
subtype1 | 7 | 0 |
subtype2 | 12 | 1 |
subtype3 | 11 | 1 |
Figure S20. Get High-res Image Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
![](D2V8.png)
P value = 0.274 (Chi-square test)
Table S23. Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #9: 'TUMOR.STAGE'
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 23 | 4 | 3 | 2 |
subtype1 | 3 | 2 | 2 | 0 |
subtype2 | 11 | 1 | 0 | 1 |
subtype3 | 9 | 1 | 1 | 1 |
Figure S21. Get High-res Image Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #9: 'TUMOR.STAGE'
![](D2V9.png)
P value = 1 (Fisher's exact test)
Table S24. Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
nPatients | NO | YES |
---|---|---|
ALL | 1 | 31 |
subtype1 | 0 | 7 |
subtype2 | 1 | 12 |
subtype3 | 0 | 12 |
Figure S22. Get High-res Image Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
![](D2V10.png)
P value = 0.357 (ANOVA)
Table S25. Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 20 | 41.1 (15.0) |
subtype1 | 3 | 40.0 (17.3) |
subtype2 | 7 | 35.0 (13.1) |
subtype3 | 10 | 45.8 (15.4) |
Figure S23. Get High-res Image Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
![](D2V11.png)
P value = 0.397 (ANOVA)
Table S26. Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 15 | 1998.4 (10.1) |
subtype1 | 3 | 1993.3 (3.5) |
subtype2 | 6 | 1996.7 (10.9) |
subtype3 | 6 | 2002.7 (11.1) |
Figure S24. Get High-res Image Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
![](D2V12.png)
P value = 0.184 (Chi-square test)
Table S27. Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
nPatients | CURRENT REFORMED SMOKER FOR < OR = 15 YEARS | CURRENT REFORMED SMOKER FOR > 15 YEARS | CURRENT SMOKER | LIFELONG NON-SMOKER |
---|---|---|---|---|
ALL | 12 | 10 | 5 | 5 |
subtype1 | 3 | 1 | 3 | 0 |
subtype2 | 3 | 6 | 1 | 3 |
subtype3 | 6 | 3 | 1 | 2 |
Figure S25. Get High-res Image Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
![](D2V13.png)
P value = 0.68 (ANOVA)
Table S28. Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 19 | 1968.5 (11.4) |
subtype1 | 6 | 1965.0 (8.8) |
subtype2 | 7 | 1969.9 (13.0) |
subtype3 | 6 | 1970.5 (12.9) |
Figure S26. Get High-res Image Clustering Approach #2: 'mRNA cHierClus subtypes' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
![](D2V14.png)
Table S29. Get Full Table Description of clustering approach #3: 'CN CNMF'
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 99 | 140 | 88 |
P value = 0.93 (logrank test)
Table S30. Clustering Approach #3: 'CN CNMF' versus Clinical Feature #1: 'Time to Death'
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 291 | 82 | 0.0 - 224.0 (10.0) |
subtype1 | 88 | 29 | 0.1 - 224.0 (11.3) |
subtype2 | 126 | 34 | 0.0 - 104.2 (9.9) |
subtype3 | 77 | 19 | 0.0 - 88.1 (8.7) |
Figure S27. Get High-res Image Clustering Approach #3: 'CN CNMF' versus Clinical Feature #1: 'Time to Death'
![](D3V1.png)
P value = 0.000119 (ANOVA)
Table S31. Clustering Approach #3: 'CN CNMF' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 296 | 65.3 (9.8) |
subtype1 | 93 | 63.2 (10.4) |
subtype2 | 124 | 68.1 (8.6) |
subtype3 | 79 | 63.2 (10.0) |
Figure S28. Get High-res Image Clustering Approach #3: 'CN CNMF' versus Clinical Feature #2: 'AGE'
![](D3V2.png)
P value = 0.103 (Fisher's exact test)
Table S32. Clustering Approach #3: 'CN CNMF' versus Clinical Feature #3: 'GENDER'
nPatients | FEMALE | MALE |
---|---|---|
ALL | 179 | 148 |
subtype1 | 60 | 39 |
subtype2 | 79 | 61 |
subtype3 | 40 | 48 |
Figure S29. Get High-res Image Clustering Approach #3: 'CN CNMF' versus Clinical Feature #3: 'GENDER'
![](D3V3.png)
P value = 0.392 (ANOVA)
Table S33. Clustering Approach #3: 'CN CNMF' versus Clinical Feature #4: 'KARNOFSKY.PERFORMANCE.SCORE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 28 | 75.4 (32.8) |
subtype1 | 8 | 62.5 (41.0) |
subtype2 | 13 | 83.1 (25.9) |
subtype3 | 7 | 75.7 (34.6) |
Figure S30. Get High-res Image Clustering Approach #3: 'CN CNMF' versus Clinical Feature #4: 'KARNOFSKY.PERFORMANCE.SCORE'
![](D3V4.png)
P value = 0.272 (Chi-square test)
Table S34. Clustering Approach #3: 'CN CNMF' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
nPatients | LUNG ACINAR ADENOCARCINOMA | LUNG ADENOCARCINOMA MIXED SUBTYPE | LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS) | LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS | LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS | LUNG CLEAR CELL ADENOCARCINOMA | LUNG MICROPAPILLARY ADENOCARCINOMA | LUNG MUCINOUS ADENOCARCINOMA | LUNG PAPILLARY ADENOCARCINOMA | LUNG SOLID PATTERN PREDOMINANT ADENOCARCINOMA | MUCINOUS (COLLOID) ADENOCARCINOMA |
---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 10 | 74 | 199 | 3 | 14 | 2 | 3 | 2 | 13 | 2 | 5 |
subtype1 | 2 | 19 | 61 | 1 | 8 | 0 | 2 | 0 | 5 | 1 | 0 |
subtype2 | 4 | 36 | 78 | 2 | 5 | 1 | 1 | 2 | 7 | 0 | 4 |
subtype3 | 4 | 19 | 60 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 |
Figure S31. Get High-res Image Clustering Approach #3: 'CN CNMF' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
![](D3V5.png)
P value = 0.304 (Chi-square test)
Table S35. Clustering Approach #3: 'CN CNMF' versus Clinical Feature #6: 'PATHOLOGY.T'
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 95 | 188 | 25 | 17 |
subtype1 | 25 | 65 | 6 | 3 |
subtype2 | 44 | 79 | 9 | 7 |
subtype3 | 26 | 44 | 10 | 7 |
Figure S32. Get High-res Image Clustering Approach #3: 'CN CNMF' versus Clinical Feature #6: 'PATHOLOGY.T'
![](D3V6.png)
P value = 0.732 (Chi-square test)
Table S36. Clustering Approach #3: 'CN CNMF' versus Clinical Feature #7: 'PATHOLOGY.N'
nPatients | N0 | N1 | N2+N3 |
---|---|---|---|
ALL | 198 | 66 | 54 |
subtype1 | 57 | 20 | 19 |
subtype2 | 90 | 27 | 19 |
subtype3 | 51 | 19 | 16 |
Figure S33. Get High-res Image Clustering Approach #3: 'CN CNMF' versus Clinical Feature #7: 'PATHOLOGY.N'
![](D3V7.png)
P value = 0.794 (Chi-square test)
Table S37. Clustering Approach #3: 'CN CNMF' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
nPatients | M0 | M1 | MX |
---|---|---|---|
ALL | 229 | 17 | 73 |
subtype1 | 67 | 6 | 24 |
subtype2 | 99 | 5 | 31 |
subtype3 | 63 | 6 | 18 |
Figure S34. Get High-res Image Clustering Approach #3: 'CN CNMF' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
![](D3V8.png)
P value = 0.118 (Chi-square test)
Table S38. Clustering Approach #3: 'CN CNMF' versus Clinical Feature #9: 'TUMOR.STAGE'
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 171 | 72 | 61 | 17 |
subtype1 | 51 | 20 | 20 | 7 |
subtype2 | 83 | 30 | 19 | 4 |
subtype3 | 37 | 22 | 22 | 6 |
Figure S35. Get High-res Image Clustering Approach #3: 'CN CNMF' versus Clinical Feature #9: 'TUMOR.STAGE'
![](D3V9.png)
P value = 0.341 (Fisher's exact test)
Table S39. Clustering Approach #3: 'CN CNMF' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
nPatients | NO | YES |
---|---|---|
ALL | 20 | 307 |
subtype1 | 6 | 93 |
subtype2 | 6 | 134 |
subtype3 | 8 | 80 |
Figure S36. Get High-res Image Clustering Approach #3: 'CN CNMF' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
![](D3V10.png)
P value = 0.167 (ANOVA)
Table S40. Clustering Approach #3: 'CN CNMF' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 228 | 39.8 (26.2) |
subtype1 | 60 | 44.7 (26.0) |
subtype2 | 97 | 36.6 (25.3) |
subtype3 | 71 | 40.1 (27.3) |
Figure S37. Get High-res Image Clustering Approach #3: 'CN CNMF' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
![](D3V11.png)
P value = 0.0242 (ANOVA)
Table S41. Clustering Approach #3: 'CN CNMF' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 164 | 1993.9 (13.8) |
subtype1 | 46 | 1995.0 (13.5) |
subtype2 | 76 | 1990.9 (14.4) |
subtype3 | 42 | 1997.9 (11.7) |
Figure S38. Get High-res Image Clustering Approach #3: 'CN CNMF' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
![](D3V12.png)
P value = 0.000111 (Chi-square test)
Table S42. Clustering Approach #3: 'CN CNMF' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
nPatients | CURRENT REFORMED SMOKER FOR < OR = 15 YEARS | CURRENT REFORMED SMOKER FOR > 15 YEARS | CURRENT SMOKER | LIFELONG NON-SMOKER |
---|---|---|---|---|
ALL | 110 | 86 | 72 | 46 |
subtype1 | 33 | 23 | 21 | 17 |
subtype2 | 45 | 49 | 18 | 23 |
subtype3 | 32 | 14 | 33 | 6 |
Figure S39. Get High-res Image Clustering Approach #3: 'CN CNMF' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
![](D3V13.png)
P value = 0.0354 (ANOVA)
Table S43. Clustering Approach #3: 'CN CNMF' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 163 | 1964.8 (13.0) |
subtype1 | 43 | 1963.3 (12.9) |
subtype2 | 66 | 1962.8 (12.6) |
subtype3 | 54 | 1968.5 (12.9) |
Figure S40. Get High-res Image Clustering Approach #3: 'CN CNMF' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
![](D3V14.png)
Table S44. Get Full Table Description of clustering approach #4: 'METHLYATION CNMF'
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 67 | 96 | 98 |
P value = 0.0209 (logrank test)
Table S45. Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #1: 'Time to Death'
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 231 | 61 | 0.0 - 224.0 (8.5) |
subtype1 | 58 | 12 | 0.1 - 224.0 (9.0) |
subtype2 | 86 | 18 | 0.0 - 88.1 (8.2) |
subtype3 | 87 | 31 | 0.0 - 77.9 (9.3) |
Figure S41. Get High-res Image Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #1: 'Time to Death'
![](D4V1.png)
P value = 0.0395 (ANOVA)
Table S46. Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 233 | 65.2 (10.0) |
subtype1 | 58 | 67.8 (8.2) |
subtype2 | 90 | 63.5 (9.9) |
subtype3 | 85 | 65.1 (10.8) |
Figure S42. Get High-res Image Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #2: 'AGE'
![](D4V2.png)
P value = 0.0767 (Fisher's exact test)
Table S47. Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #3: 'GENDER'
nPatients | FEMALE | MALE |
---|---|---|
ALL | 143 | 118 |
subtype1 | 44 | 23 |
subtype2 | 46 | 50 |
subtype3 | 53 | 45 |
Figure S43. Get High-res Image Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #3: 'GENDER'
![](D4V3.png)
P value = 0.764 (ANOVA)
Table S48. Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #4: 'KARNOFSKY.PERFORMANCE.SCORE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 21 | 73.8 (32.5) |
subtype1 | 8 | 70.0 (43.4) |
subtype2 | 9 | 80.0 (11.2) |
subtype3 | 4 | 67.5 (45.7) |
Figure S44. Get High-res Image Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #4: 'KARNOFSKY.PERFORMANCE.SCORE'
![](D4V4.png)
P value = 0.0709 (Chi-square test)
Table S49. Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
nPatients | LUNG ACINAR ADENOCARCINOMA | LUNG ADENOCARCINOMA MIXED SUBTYPE | LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS) | LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS | LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS | LUNG CLEAR CELL ADENOCARCINOMA | LUNG MICROPAPILLARY ADENOCARCINOMA | LUNG MUCINOUS ADENOCARCINOMA | LUNG PAPILLARY ADENOCARCINOMA | LUNG SOLID PATTERN PREDOMINANT ADENOCARCINOMA | MUCINOUS (COLLOID) ADENOCARCINOMA |
---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 10 | 59 | 151 | 3 | 14 | 1 | 2 | 2 | 12 | 2 | 5 |
subtype1 | 5 | 15 | 30 | 1 | 7 | 0 | 1 | 2 | 4 | 0 | 2 |
subtype2 | 4 | 27 | 56 | 1 | 3 | 0 | 1 | 0 | 4 | 0 | 0 |
subtype3 | 1 | 17 | 65 | 1 | 4 | 1 | 0 | 0 | 4 | 2 | 3 |
Figure S45. Get High-res Image Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
![](D4V5.png)
P value = 0.55 (Chi-square test)
Table S50. Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #6: 'PATHOLOGY.T'
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 78 | 146 | 20 | 14 |
subtype1 | 22 | 37 | 5 | 2 |
subtype2 | 26 | 52 | 10 | 8 |
subtype3 | 30 | 57 | 5 | 4 |
Figure S46. Get High-res Image Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #6: 'PATHOLOGY.T'
![](D4V6.png)
P value = 0.391 (Chi-square test)
Table S51. Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #7: 'PATHOLOGY.N'
nPatients | N0 | N1 | N2+N3 |
---|---|---|---|
ALL | 157 | 52 | 44 |
subtype1 | 44 | 12 | 8 |
subtype2 | 61 | 18 | 15 |
subtype3 | 52 | 22 | 21 |
Figure S47. Get High-res Image Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #7: 'PATHOLOGY.N'
![](D4V7.png)
P value = 0.687 (Chi-square test)
Table S52. Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
nPatients | M0 | M1 | MX |
---|---|---|---|
ALL | 168 | 11 | 75 |
subtype1 | 42 | 1 | 20 |
subtype2 | 61 | 6 | 26 |
subtype3 | 65 | 4 | 29 |
Figure S48. Get High-res Image Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
![](D4V8.png)
P value = 0.716 (Chi-square test)
Table S53. Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #9: 'TUMOR.STAGE'
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 134 | 58 | 51 | 12 |
subtype1 | 38 | 15 | 10 | 1 |
subtype2 | 48 | 21 | 19 | 6 |
subtype3 | 48 | 22 | 22 | 5 |
Figure S49. Get High-res Image Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #9: 'TUMOR.STAGE'
![](D4V9.png)
P value = 0.137 (Fisher's exact test)
Table S54. Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
nPatients | NO | YES |
---|---|---|
ALL | 16 | 245 |
subtype1 | 2 | 65 |
subtype2 | 4 | 92 |
subtype3 | 10 | 88 |
Figure S50. Get High-res Image Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
![](D4V10.png)
P value = 0.374 (ANOVA)
Table S55. Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 178 | 38.6 (25.8) |
subtype1 | 39 | 33.8 (20.4) |
subtype2 | 73 | 41.0 (30.1) |
subtype3 | 66 | 38.7 (23.4) |
Figure S51. Get High-res Image Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
![](D4V11.png)
P value = 0.357 (ANOVA)
Table S56. Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 136 | 1994.1 (13.3) |
subtype1 | 40 | 1991.8 (10.7) |
subtype2 | 55 | 1995.8 (14.4) |
subtype3 | 41 | 1994.1 (14.2) |
Figure S52. Get High-res Image Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
![](D4V12.png)
P value = 0.000775 (Chi-square test)
Table S57. Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
nPatients | CURRENT REFORMED SMOKER FOR < OR = 15 YEARS | CURRENT REFORMED SMOKER FOR > 15 YEARS | CURRENT SMOKER | LIFELONG NON-SMOKER |
---|---|---|---|---|
ALL | 87 | 68 | 56 | 37 |
subtype1 | 18 | 25 | 5 | 17 |
subtype2 | 37 | 21 | 29 | 8 |
subtype3 | 32 | 22 | 22 | 12 |
Figure S53. Get High-res Image Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
![](D4V13.png)
P value = 0.516 (ANOVA)
Table S58. Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 133 | 1964.7 (12.7) |
subtype1 | 30 | 1962.5 (11.5) |
subtype2 | 61 | 1964.9 (13.6) |
subtype3 | 42 | 1966.0 (12.4) |
Figure S54. Get High-res Image Clustering Approach #4: 'METHLYATION CNMF' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
![](D4V14.png)
Table S59. Get Full Table Description of clustering approach #5: 'RPPA CNMF subtypes'
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 90 | 75 | 71 |
P value = 0.0585 (logrank test)
Table S60. Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #1: 'Time to Death'
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 213 | 66 | 0.0 - 224.0 (12.3) |
subtype1 | 75 | 27 | 0.0 - 163.1 (12.1) |
subtype2 | 71 | 17 | 0.2 - 224.0 (13.7) |
subtype3 | 67 | 22 | 0.0 - 83.8 (9.0) |
Figure S55. Get High-res Image Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #1: 'Time to Death'
![](D5V1.png)
P value = 0.0146 (ANOVA)
Table S61. Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 215 | 64.8 (9.9) |
subtype1 | 78 | 64.2 (10.2) |
subtype2 | 72 | 67.4 (9.0) |
subtype3 | 65 | 62.7 (9.9) |
Figure S56. Get High-res Image Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #2: 'AGE'
![](D5V2.png)
P value = 0.231 (Fisher's exact test)
Table S62. Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #3: 'GENDER'
nPatients | FEMALE | MALE |
---|---|---|
ALL | 131 | 105 |
subtype1 | 56 | 34 |
subtype2 | 40 | 35 |
subtype3 | 35 | 36 |
Figure S57. Get High-res Image Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #3: 'GENDER'
![](D5V3.png)
P value = 0.0491 (ANOVA)
Table S63. Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #4: 'KARNOFSKY.PERFORMANCE.SCORE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 20 | 68.0 (36.1) |
subtype1 | 7 | 44.3 (42.8) |
subtype2 | 6 | 91.7 (7.5) |
subtype3 | 7 | 71.4 (31.8) |
Figure S58. Get High-res Image Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #4: 'KARNOFSKY.PERFORMANCE.SCORE'
![](D5V4.png)
P value = 0.166 (Chi-square test)
Table S64. Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
nPatients | LUNG ACINAR ADENOCARCINOMA | LUNG ADENOCARCINOMA MIXED SUBTYPE | LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS) | LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS | LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS | LUNG CLEAR CELL ADENOCARCINOMA | LUNG MICROPAPILLARY ADENOCARCINOMA | LUNG MUCINOUS ADENOCARCINOMA | LUNG PAPILLARY ADENOCARCINOMA | LUNG SOLID PATTERN PREDOMINANT ADENOCARCINOMA | MUCINOUS (COLLOID) ADENOCARCINOMA |
---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 6 | 52 | 150 | 3 | 10 | 1 | 2 | 2 | 6 | 1 | 3 |
subtype1 | 2 | 19 | 58 | 1 | 3 | 1 | 1 | 1 | 2 | 1 | 1 |
subtype2 | 3 | 21 | 36 | 2 | 6 | 0 | 1 | 0 | 4 | 0 | 2 |
subtype3 | 1 | 12 | 56 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
Figure S59. Get High-res Image Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
![](D5V5.png)
P value = 0.184 (Chi-square test)
Table S65. Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #6: 'PATHOLOGY.T'
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 64 | 141 | 17 | 13 |
subtype1 | 26 | 50 | 9 | 4 |
subtype2 | 23 | 43 | 2 | 7 |
subtype3 | 15 | 48 | 6 | 2 |
Figure S60. Get High-res Image Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #6: 'PATHOLOGY.T'
![](D5V6.png)
P value = 0.439 (Chi-square test)
Table S66. Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #7: 'PATHOLOGY.N'
nPatients | N0 | N1 | N2+N3 |
---|---|---|---|
ALL | 140 | 46 | 44 |
subtype1 | 48 | 22 | 16 |
subtype2 | 49 | 13 | 12 |
subtype3 | 43 | 11 | 16 |
Figure S61. Get High-res Image Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #7: 'PATHOLOGY.N'
![](D5V7.png)
P value = 0.851 (Chi-square test)
Table S67. Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
nPatients | M0 | M1 | MX |
---|---|---|---|
ALL | 165 | 12 | 55 |
subtype1 | 63 | 5 | 19 |
subtype2 | 50 | 4 | 21 |
subtype3 | 52 | 3 | 15 |
Figure S62. Get High-res Image Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
![](D5V8.png)
P value = 0.903 (Chi-square test)
Table S68. Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #9: 'TUMOR.STAGE'
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 122 | 49 | 49 | 13 |
subtype1 | 45 | 20 | 17 | 5 |
subtype2 | 39 | 17 | 14 | 5 |
subtype3 | 38 | 12 | 18 | 3 |
Figure S63. Get High-res Image Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #9: 'TUMOR.STAGE'
![](D5V9.png)
P value = 0.893 (Fisher's exact test)
Table S69. Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
nPatients | NO | YES |
---|---|---|
ALL | 15 | 221 |
subtype1 | 6 | 84 |
subtype2 | 4 | 71 |
subtype3 | 5 | 66 |
Figure S64. Get High-res Image Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
![](D5V10.png)
P value = 0.479 (ANOVA)
Table S70. Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 171 | 40.5 (26.7) |
subtype1 | 55 | 42.7 (28.8) |
subtype2 | 64 | 37.3 (25.3) |
subtype3 | 52 | 42.2 (26.2) |
Figure S65. Get High-res Image Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
![](D5V11.png)
P value = 0.00862 (ANOVA)
Table S71. Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 122 | 1994.3 (13.5) |
subtype1 | 45 | 1990.2 (14.9) |
subtype2 | 43 | 1994.3 (12.4) |
subtype3 | 34 | 1999.6 (11.2) |
Figure S66. Get High-res Image Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
![](D5V12.png)
P value = 0.000452 (Chi-square test)
Table S72. Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
nPatients | CURRENT REFORMED SMOKER FOR < OR = 15 YEARS | CURRENT REFORMED SMOKER FOR > 15 YEARS | CURRENT SMOKER | LIFELONG NON-SMOKER |
---|---|---|---|---|
ALL | 84 | 59 | 52 | 31 |
subtype1 | 29 | 25 | 12 | 19 |
subtype2 | 25 | 26 | 16 | 6 |
subtype3 | 30 | 8 | 24 | 6 |
Figure S67. Get High-res Image Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
![](D5V13.png)
P value = 0.0307 (ANOVA)
Table S73. Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 119 | 1964.7 (13.7) |
subtype1 | 33 | 1964.2 (14.3) |
subtype2 | 46 | 1961.4 (12.8) |
subtype3 | 40 | 1969.1 (13.2) |
Figure S68. Get High-res Image Clustering Approach #5: 'RPPA CNMF subtypes' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
![](D5V14.png)
Table S74. Get Full Table Description of clustering approach #6: 'RPPA cHierClus subtypes'
Cluster Labels | 1 | 2 | 3 | 4 |
---|---|---|---|---|
Number of samples | 23 | 73 | 84 | 56 |
P value = 0.087 (logrank test)
Table S75. Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #1: 'Time to Death'
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 213 | 66 | 0.0 - 224.0 (12.3) |
subtype1 | 18 | 4 | 0.0 - 63.7 (7.1) |
subtype2 | 69 | 22 | 0.0 - 83.8 (8.8) |
subtype3 | 72 | 27 | 0.7 - 163.1 (13.5) |
subtype4 | 54 | 13 | 0.1 - 224.0 (14.5) |
Figure S69. Get High-res Image Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #1: 'Time to Death'
![](D6V1.png)
P value = 0.00448 (ANOVA)
Table S76. Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 215 | 64.8 (9.9) |
subtype1 | 20 | 68.0 (6.8) |
subtype2 | 67 | 62.7 (11.0) |
subtype3 | 75 | 63.5 (9.8) |
subtype4 | 53 | 68.2 (8.2) |
Figure S70. Get High-res Image Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #2: 'AGE'
![](D6V2.png)
P value = 0.147 (Fisher's exact test)
Table S77. Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #3: 'GENDER'
nPatients | FEMALE | MALE |
---|---|---|
ALL | 131 | 105 |
subtype1 | 15 | 8 |
subtype2 | 37 | 36 |
subtype3 | 53 | 31 |
subtype4 | 26 | 30 |
Figure S71. Get High-res Image Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #3: 'GENDER'
![](D6V3.png)
P value = 0.302 (ANOVA)
Table S78. Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #4: 'KARNOFSKY.PERFORMANCE.SCORE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 20 | 68.0 (36.1) |
subtype1 | 4 | 70.0 (46.9) |
subtype2 | 7 | 71.4 (31.8) |
subtype3 | 5 | 44.0 (41.6) |
subtype4 | 4 | 90.0 (8.2) |
Figure S72. Get High-res Image Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #4: 'KARNOFSKY.PERFORMANCE.SCORE'
![](D6V4.png)
P value = 0.00633 (Chi-square test)
Table S79. Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
nPatients | LUNG ACINAR ADENOCARCINOMA | LUNG ADENOCARCINOMA MIXED SUBTYPE | LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS) | LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS | LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS | LUNG CLEAR CELL ADENOCARCINOMA | LUNG MICROPAPILLARY ADENOCARCINOMA | LUNG MUCINOUS ADENOCARCINOMA | LUNG PAPILLARY ADENOCARCINOMA | LUNG SOLID PATTERN PREDOMINANT ADENOCARCINOMA | MUCINOUS (COLLOID) ADENOCARCINOMA |
---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 6 | 52 | 150 | 3 | 10 | 1 | 2 | 2 | 6 | 1 | 3 |
subtype1 | 1 | 4 | 12 | 0 | 3 | 0 | 2 | 0 | 1 | 0 | 0 |
subtype2 | 2 | 12 | 54 | 0 | 2 | 1 | 0 | 1 | 1 | 0 | 0 |
subtype3 | 1 | 19 | 58 | 0 | 2 | 0 | 0 | 0 | 2 | 1 | 1 |
subtype4 | 2 | 17 | 26 | 3 | 3 | 0 | 0 | 1 | 2 | 0 | 2 |
Figure S73. Get High-res Image Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
![](D6V5.png)
P value = 0.658 (Chi-square test)
Table S80. Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #6: 'PATHOLOGY.T'
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 64 | 141 | 17 | 13 |
subtype1 | 7 | 11 | 2 | 3 |
subtype2 | 19 | 44 | 7 | 3 |
subtype3 | 21 | 55 | 3 | 4 |
subtype4 | 17 | 31 | 5 | 3 |
Figure S74. Get High-res Image Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #6: 'PATHOLOGY.T'
![](D6V6.png)
P value = 0.481 (Chi-square test)
Table S81. Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #7: 'PATHOLOGY.N'
nPatients | N0 | N1 | N2+N3 |
---|---|---|---|
ALL | 140 | 46 | 44 |
subtype1 | 15 | 4 | 4 |
subtype2 | 45 | 10 | 17 |
subtype3 | 43 | 21 | 15 |
subtype4 | 37 | 11 | 8 |
Figure S75. Get High-res Image Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #7: 'PATHOLOGY.N'
![](D6V7.png)
P value = 0.761 (Chi-square test)
Table S82. Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
nPatients | M0 | M1 | MX |
---|---|---|---|
ALL | 165 | 12 | 55 |
subtype1 | 14 | 1 | 8 |
subtype2 | 53 | 2 | 17 |
subtype3 | 58 | 6 | 18 |
subtype4 | 40 | 3 | 12 |
Figure S76. Get High-res Image Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
![](D6V8.png)
P value = 0.98 (Chi-square test)
Table S83. Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #9: 'TUMOR.STAGE'
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 122 | 49 | 49 | 13 |
subtype1 | 12 | 5 | 5 | 1 |
subtype2 | 37 | 14 | 19 | 3 |
subtype3 | 44 | 18 | 14 | 6 |
subtype4 | 29 | 12 | 11 | 3 |
Figure S77. Get High-res Image Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #9: 'TUMOR.STAGE'
![](D6V9.png)
P value = 0.373 (Fisher's exact test)
Table S84. Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
nPatients | NO | YES |
---|---|---|
ALL | 15 | 221 |
subtype1 | 0 | 23 |
subtype2 | 7 | 66 |
subtype3 | 6 | 78 |
subtype4 | 2 | 54 |
Figure S78. Get High-res Image Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
![](D6V10.png)
P value = 0.244 (ANOVA)
Table S85. Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 171 | 40.5 (26.7) |
subtype1 | 17 | 48.7 (34.8) |
subtype2 | 57 | 43.9 (27.2) |
subtype3 | 47 | 38.4 (25.4) |
subtype4 | 50 | 36.0 (23.8) |
Figure S79. Get High-res Image Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
![](D6V11.png)
P value = 0.0126 (ANOVA)
Table S86. Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 122 | 1994.3 (13.5) |
subtype1 | 16 | 1994.6 (11.5) |
subtype2 | 32 | 2000.8 (10.7) |
subtype3 | 39 | 1991.3 (15.3) |
subtype4 | 35 | 1991.7 (13.1) |
Figure S80. Get High-res Image Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
![](D6V12.png)
P value = 0.000189 (Chi-square test)
Table S87. Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
nPatients | CURRENT REFORMED SMOKER FOR < OR = 15 YEARS | CURRENT REFORMED SMOKER FOR > 15 YEARS | CURRENT SMOKER | LIFELONG NON-SMOKER |
---|---|---|---|---|
ALL | 84 | 59 | 52 | 31 |
subtype1 | 13 | 5 | 0 | 4 |
subtype2 | 30 | 8 | 25 | 7 |
subtype3 | 25 | 23 | 15 | 16 |
subtype4 | 16 | 23 | 12 | 4 |
Figure S81. Get High-res Image Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
![](D6V13.png)
P value = 0.0134 (ANOVA)
Table S88. Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 119 | 1964.7 (13.7) |
subtype1 | 11 | 1962.1 (10.6) |
subtype2 | 43 | 1969.5 (13.7) |
subtype3 | 29 | 1964.8 (12.4) |
subtype4 | 36 | 1959.8 (14.0) |
Figure S82. Get High-res Image Clustering Approach #6: 'RPPA cHierClus subtypes' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
![](D6V14.png)
Table S89. Get Full Table Description of clustering approach #7: 'RNAseq CNMF subtypes'
Cluster Labels | 1 | 2 | 3 | 4 | 5 |
---|---|---|---|---|---|
Number of samples | 94 | 67 | 49 | 74 | 40 |
P value = 0.000633 (logrank test)
Table S90. Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #1: 'Time to Death'
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 288 | 80 | 0.0 - 224.0 (10.1) |
subtype1 | 85 | 23 | 0.0 - 163.1 (8.1) |
subtype2 | 59 | 13 | 0.1 - 104.2 (10.8) |
subtype3 | 44 | 20 | 0.0 - 47.6 (9.5) |
subtype4 | 64 | 17 | 0.1 - 88.1 (15.7) |
subtype5 | 36 | 7 | 0.1 - 224.0 (12.1) |
Figure S83. Get High-res Image Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #1: 'Time to Death'
![](D7V1.png)
P value = 0.00176 (ANOVA)
Table S91. Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 293 | 65.4 (9.8) |
subtype1 | 85 | 63.4 (10.7) |
subtype2 | 61 | 68.3 (7.7) |
subtype3 | 44 | 68.8 (9.4) |
subtype4 | 67 | 63.4 (9.3) |
subtype5 | 36 | 64.9 (10.3) |
Figure S84. Get High-res Image Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #2: 'AGE'
![](D7V2.png)
P value = 0.0417 (Chi-square test)
Table S92. Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #3: 'GENDER'
nPatients | FEMALE | MALE |
---|---|---|
ALL | 177 | 147 |
subtype1 | 52 | 42 |
subtype2 | 44 | 23 |
subtype3 | 22 | 27 |
subtype4 | 33 | 41 |
subtype5 | 26 | 14 |
Figure S85. Get High-res Image Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #3: 'GENDER'
![](D7V3.png)
P value = 0.431 (ANOVA)
Table S93. Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #4: 'KARNOFSKY.PERFORMANCE.SCORE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 28 | 75.4 (32.8) |
subtype1 | 10 | 67.0 (37.4) |
subtype2 | 7 | 92.9 (7.6) |
subtype4 | 7 | 74.3 (33.6) |
subtype5 | 4 | 67.5 (45.7) |
Figure S86. Get High-res Image Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #4: 'KARNOFSKY.PERFORMANCE.SCORE'
![](D7V4.png)
P value = 0.0922 (Chi-square test)
Table S94. Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
nPatients | LUNG ACINAR ADENOCARCINOMA | LUNG ADENOCARCINOMA MIXED SUBTYPE | LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS) | LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS | LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS | LUNG CLEAR CELL ADENOCARCINOMA | LUNG MICROPAPILLARY ADENOCARCINOMA | LUNG MUCINOUS ADENOCARCINOMA | LUNG PAPILLARY ADENOCARCINOMA | LUNG SOLID PATTERN PREDOMINANT ADENOCARCINOMA | MUCINOUS (COLLOID) ADENOCARCINOMA |
---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 10 | 73 | 198 | 3 | 14 | 2 | 3 | 2 | 13 | 2 | 4 |
subtype1 | 1 | 15 | 68 | 0 | 3 | 1 | 2 | 0 | 4 | 0 | 0 |
subtype2 | 4 | 18 | 35 | 1 | 6 | 0 | 1 | 0 | 2 | 0 | 0 |
subtype3 | 1 | 12 | 28 | 1 | 0 | 1 | 0 | 1 | 2 | 0 | 3 |
subtype4 | 2 | 16 | 47 | 0 | 4 | 0 | 0 | 0 | 3 | 2 | 0 |
subtype5 | 2 | 12 | 20 | 1 | 1 | 0 | 0 | 1 | 2 | 0 | 1 |
Figure S87. Get High-res Image Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
![](D7V5.png)
P value = 0.297 (Chi-square test)
Table S95. Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #6: 'PATHOLOGY.T'
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 94 | 185 | 26 | 17 |
subtype1 | 24 | 58 | 7 | 5 |
subtype2 | 28 | 33 | 3 | 3 |
subtype3 | 8 | 30 | 6 | 4 |
subtype4 | 19 | 45 | 6 | 4 |
subtype5 | 15 | 19 | 4 | 1 |
Figure S88. Get High-res Image Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #6: 'PATHOLOGY.T'
![](D7V6.png)
P value = 0.00287 (Chi-square test)
Table S96. Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #7: 'PATHOLOGY.N'
nPatients | N0 | N1 | N2+N3 |
---|---|---|---|
ALL | 197 | 65 | 53 |
subtype1 | 50 | 24 | 19 |
subtype2 | 48 | 11 | 7 |
subtype3 | 20 | 14 | 14 |
subtype4 | 57 | 8 | 8 |
subtype5 | 22 | 8 | 5 |
Figure S89. Get High-res Image Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #7: 'PATHOLOGY.N'
![](D7V7.png)
P value = 0.85 (Chi-square test)
Table S97. Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
nPatients | M0 | M1 | MX |
---|---|---|---|
ALL | 225 | 17 | 74 |
subtype1 | 66 | 4 | 22 |
subtype2 | 48 | 2 | 15 |
subtype3 | 38 | 3 | 8 |
subtype4 | 49 | 5 | 18 |
subtype5 | 24 | 3 | 11 |
Figure S90. Get High-res Image Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
![](D7V8.png)
P value = 0.165 (Chi-square test)
Table S98. Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #9: 'TUMOR.STAGE'
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 169 | 71 | 61 | 17 |
subtype1 | 42 | 25 | 20 | 5 |
subtype2 | 41 | 13 | 8 | 2 |
subtype3 | 18 | 12 | 16 | 3 |
subtype4 | 45 | 13 | 12 | 4 |
subtype5 | 23 | 8 | 5 | 3 |
Figure S91. Get High-res Image Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #9: 'TUMOR.STAGE'
![](D7V9.png)
P value = 0.745 (Chi-square test)
Table S99. Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
nPatients | NO | YES |
---|---|---|
ALL | 18 | 306 |
subtype1 | 6 | 88 |
subtype2 | 4 | 63 |
subtype3 | 4 | 45 |
subtype4 | 2 | 72 |
subtype5 | 2 | 38 |
Figure S92. Get High-res Image Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
![](D7V10.png)
P value = 0.0871 (ANOVA)
Table S100. Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 227 | 39.7 (26.2) |
subtype1 | 64 | 42.7 (24.3) |
subtype2 | 45 | 30.2 (21.4) |
subtype3 | 37 | 39.5 (27.1) |
subtype4 | 55 | 43.8 (30.7) |
subtype5 | 26 | 40.5 (24.5) |
Figure S93. Get High-res Image Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
![](D7V11.png)
P value = 0.0716 (ANOVA)
Table S101. Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 165 | 1993.9 (13.7) |
subtype1 | 47 | 1995.7 (13.3) |
subtype2 | 39 | 1989.7 (14.2) |
subtype3 | 24 | 1991.4 (15.8) |
subtype4 | 33 | 1998.2 (12.3) |
subtype5 | 22 | 1993.4 (11.6) |
Figure S94. Get High-res Image Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
![](D7V12.png)
P value = 0.00141 (Chi-square test)
Table S102. Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
nPatients | CURRENT REFORMED SMOKER FOR < OR = 15 YEARS | CURRENT REFORMED SMOKER FOR > 15 YEARS | CURRENT SMOKER | LIFELONG NON-SMOKER |
---|---|---|---|---|
ALL | 110 | 87 | 71 | 45 |
subtype1 | 35 | 22 | 19 | 16 |
subtype2 | 16 | 30 | 7 | 11 |
subtype3 | 19 | 11 | 11 | 5 |
subtype4 | 27 | 11 | 28 | 7 |
subtype5 | 13 | 13 | 6 | 6 |
Figure S95. Get High-res Image Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
![](D7V13.png)
P value = 0.309 (ANOVA)
Table S103. Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 163 | 1964.7 (13.0) |
subtype1 | 43 | 1967.2 (14.0) |
subtype2 | 34 | 1960.8 (11.1) |
subtype3 | 25 | 1964.1 (14.8) |
subtype4 | 42 | 1965.5 (12.9) |
subtype5 | 19 | 1965.3 (11.2) |
Figure S96. Get High-res Image Clustering Approach #7: 'RNAseq CNMF subtypes' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
![](D7V14.png)
Table S104. Get Full Table Description of clustering approach #8: 'RNAseq cHierClus subtypes'
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 139 | 97 | 88 |
P value = 0.0136 (logrank test)
Table S105. Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #1: 'Time to Death'
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 288 | 80 | 0.0 - 224.0 (10.1) |
subtype1 | 123 | 29 | 0.0 - 224.0 (13.2) |
subtype2 | 87 | 28 | 0.1 - 83.8 (11.6) |
subtype3 | 78 | 23 | 0.0 - 77.9 (8.2) |
Figure S97. Get High-res Image Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #1: 'Time to Death'
![](D8V1.png)
P value = 0.156 (ANOVA)
Table S106. Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 293 | 65.4 (9.8) |
subtype1 | 126 | 66.7 (9.1) |
subtype2 | 88 | 64.4 (9.6) |
subtype3 | 79 | 64.6 (11.1) |
Figure S98. Get High-res Image Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #2: 'AGE'
![](D8V2.png)
P value = 0.00131 (Fisher's exact test)
Table S107. Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #3: 'GENDER'
nPatients | FEMALE | MALE |
---|---|---|
ALL | 177 | 147 |
subtype1 | 85 | 54 |
subtype2 | 38 | 59 |
subtype3 | 54 | 34 |
Figure S99. Get High-res Image Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #3: 'GENDER'
![](D8V3.png)
P value = 0.704 (ANOVA)
Table S108. Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #4: 'KARNOFSKY.PERFORMANCE.SCORE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 28 | 75.4 (32.8) |
subtype1 | 12 | 76.7 (36.5) |
subtype2 | 6 | 83.3 (5.2) |
subtype3 | 10 | 69.0 (38.7) |
Figure S100. Get High-res Image Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #4: 'KARNOFSKY.PERFORMANCE.SCORE'
![](D8V4.png)
P value = 0.112 (Chi-square test)
Table S109. Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
nPatients | LUNG ACINAR ADENOCARCINOMA | LUNG ADENOCARCINOMA MIXED SUBTYPE | LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS) | LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS | LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS | LUNG CLEAR CELL ADENOCARCINOMA | LUNG MICROPAPILLARY ADENOCARCINOMA | LUNG MUCINOUS ADENOCARCINOMA | LUNG PAPILLARY ADENOCARCINOMA | LUNG SOLID PATTERN PREDOMINANT ADENOCARCINOMA | MUCINOUS (COLLOID) ADENOCARCINOMA |
---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 10 | 73 | 198 | 3 | 14 | 2 | 3 | 2 | 13 | 2 | 4 |
subtype1 | 7 | 35 | 74 | 3 | 9 | 0 | 1 | 2 | 6 | 0 | 2 |
subtype2 | 2 | 23 | 62 | 0 | 2 | 1 | 0 | 0 | 3 | 2 | 2 |
subtype3 | 1 | 15 | 62 | 0 | 3 | 1 | 2 | 0 | 4 | 0 | 0 |
Figure S101. Get High-res Image Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
![](D8V5.png)
P value = 0.526 (Chi-square test)
Table S110. Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #6: 'PATHOLOGY.T'
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 94 | 185 | 26 | 17 |
subtype1 | 49 | 72 | 11 | 6 |
subtype2 | 23 | 60 | 7 | 6 |
subtype3 | 22 | 53 | 8 | 5 |
Figure S102. Get High-res Image Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #6: 'PATHOLOGY.T'
![](D8V6.png)
P value = 0.0711 (Chi-square test)
Table S111. Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #7: 'PATHOLOGY.N'
nPatients | N0 | N1 | N2+N3 |
---|---|---|---|
ALL | 197 | 65 | 53 |
subtype1 | 92 | 28 | 14 |
subtype2 | 58 | 16 | 21 |
subtype3 | 47 | 21 | 18 |
Figure S103. Get High-res Image Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #7: 'PATHOLOGY.N'
![](D8V7.png)
P value = 0.791 (Chi-square test)
Table S112. Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
nPatients | M0 | M1 | MX |
---|---|---|---|
ALL | 225 | 17 | 74 |
subtype1 | 94 | 7 | 33 |
subtype2 | 66 | 7 | 22 |
subtype3 | 65 | 3 | 19 |
Figure S104. Get High-res Image Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
![](D8V8.png)
P value = 0.14 (Chi-square test)
Table S113. Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #9: 'TUMOR.STAGE'
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 169 | 71 | 61 | 17 |
subtype1 | 81 | 30 | 16 | 7 |
subtype2 | 48 | 19 | 24 | 6 |
subtype3 | 40 | 22 | 21 | 4 |
Figure S105. Get High-res Image Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #9: 'TUMOR.STAGE'
![](D8V9.png)
P value = 0.677 (Fisher's exact test)
Table S114. Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
nPatients | NO | YES |
---|---|---|
ALL | 18 | 306 |
subtype1 | 6 | 133 |
subtype2 | 6 | 91 |
subtype3 | 6 | 82 |
Figure S106. Get High-res Image Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
![](D8V10.png)
P value = 0.269 (ANOVA)
Table S115. Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 227 | 39.7 (26.2) |
subtype1 | 93 | 36.4 (26.7) |
subtype2 | 75 | 42.7 (27.7) |
subtype3 | 59 | 41.2 (23.1) |
Figure S107. Get High-res Image Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
![](D8V11.png)
P value = 0.0194 (ANOVA)
Table S116. Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 165 | 1993.9 (13.7) |
subtype1 | 79 | 1990.9 (14.1) |
subtype2 | 45 | 1997.7 (12.2) |
subtype3 | 41 | 1995.4 (13.5) |
Figure S108. Get High-res Image Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
![](D8V12.png)
P value = 1.78e-05 (Chi-square test)
Table S117. Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
nPatients | CURRENT REFORMED SMOKER FOR < OR = 15 YEARS | CURRENT REFORMED SMOKER FOR > 15 YEARS | CURRENT SMOKER | LIFELONG NON-SMOKER |
---|---|---|---|---|
ALL | 110 | 87 | 71 | 45 |
subtype1 | 43 | 52 | 16 | 22 |
subtype2 | 39 | 15 | 34 | 7 |
subtype3 | 28 | 20 | 21 | 16 |
Figure S109. Get High-res Image Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
![](D8V13.png)
P value = 0.216 (ANOVA)
Table S118. Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 163 | 1964.7 (13.0) |
subtype1 | 67 | 1962.6 (12.7) |
subtype2 | 55 | 1966.4 (12.8) |
subtype3 | 41 | 1966.0 (13.6) |
Figure S110. Get High-res Image Clustering Approach #8: 'RNAseq cHierClus subtypes' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
![](D8V14.png)
Table S119. Get Full Table Description of clustering approach #9: 'MIRseq CNMF subtypes'
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 125 | 133 | 63 |
P value = 0.5 (logrank test)
Table S120. Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #1: 'Time to Death'
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 285 | 80 | 0.0 - 224.0 (10.0) |
subtype1 | 112 | 29 | 0.1 - 163.1 (11.7) |
subtype2 | 115 | 32 | 0.0 - 83.8 (9.8) |
subtype3 | 58 | 19 | 0.0 - 224.0 (10.1) |
Figure S111. Get High-res Image Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #1: 'Time to Death'
![](D9V1.png)
P value = 0.637 (ANOVA)
Table S121. Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 291 | 65.3 (9.9) |
subtype1 | 116 | 65.9 (9.8) |
subtype2 | 121 | 65.1 (10.2) |
subtype3 | 54 | 64.4 (9.6) |
Figure S112. Get High-res Image Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #2: 'AGE'
![](D9V2.png)
P value = 0.791 (Fisher's exact test)
Table S122. Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #3: 'GENDER'
nPatients | FEMALE | MALE |
---|---|---|
ALL | 177 | 144 |
subtype1 | 69 | 56 |
subtype2 | 71 | 62 |
subtype3 | 37 | 26 |
Figure S113. Get High-res Image Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #3: 'GENDER'
![](D9V3.png)
P value = 0.933 (ANOVA)
Table S123. Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #4: 'KARNOFSKY.PERFORMANCE.SCORE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 26 | 73.5 (33.3) |
subtype1 | 11 | 73.6 (37.5) |
subtype2 | 12 | 71.7 (34.1) |
subtype3 | 3 | 80.0 (20.0) |
Figure S114. Get High-res Image Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #4: 'KARNOFSKY.PERFORMANCE.SCORE'
![](D9V4.png)
P value = 0.087 (Chi-square test)
Table S124. Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
nPatients | LUNG ACINAR ADENOCARCINOMA | LUNG ADENOCARCINOMA MIXED SUBTYPE | LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS) | LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS | LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS | LUNG CLEAR CELL ADENOCARCINOMA | LUNG MICROPAPILLARY ADENOCARCINOMA | LUNG MUCINOUS ADENOCARCINOMA | LUNG PAPILLARY ADENOCARCINOMA | LUNG SOLID PATTERN PREDOMINANT ADENOCARCINOMA | MUCINOUS (COLLOID) ADENOCARCINOMA |
---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 10 | 72 | 198 | 3 | 14 | 2 | 2 | 1 | 13 | 1 | 5 |
subtype1 | 4 | 32 | 66 | 2 | 9 | 0 | 1 | 1 | 8 | 0 | 2 |
subtype2 | 5 | 34 | 85 | 0 | 3 | 2 | 0 | 0 | 2 | 1 | 1 |
subtype3 | 1 | 6 | 47 | 1 | 2 | 0 | 1 | 0 | 3 | 0 | 2 |
Figure S115. Get High-res Image Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
![](D9V5.png)
P value = 0.456 (Chi-square test)
Table S125. Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #6: 'PATHOLOGY.T'
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 91 | 184 | 26 | 17 |
subtype1 | 44 | 64 | 9 | 7 |
subtype2 | 32 | 81 | 11 | 8 |
subtype3 | 15 | 39 | 6 | 2 |
Figure S116. Get High-res Image Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #6: 'PATHOLOGY.T'
![](D9V6.png)
P value = 0.961 (Chi-square test)
Table S126. Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #7: 'PATHOLOGY.N'
nPatients | N0 | N1 | N2+N3 |
---|---|---|---|
ALL | 192 | 65 | 54 |
subtype1 | 74 | 27 | 19 |
subtype2 | 81 | 26 | 23 |
subtype3 | 37 | 12 | 12 |
Figure S117. Get High-res Image Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #7: 'PATHOLOGY.N'
![](D9V7.png)
P value = 0.275 (Chi-square test)
Table S127. Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
nPatients | M0 | M1 | MX |
---|---|---|---|
ALL | 224 | 15 | 74 |
subtype1 | 85 | 6 | 30 |
subtype2 | 100 | 7 | 24 |
subtype3 | 39 | 2 | 20 |
Figure S118. Get High-res Image Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
![](D9V8.png)
P value = 0.738 (Chi-square test)
Table S128. Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #9: 'TUMOR.STAGE'
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 167 | 70 | 62 | 16 |
subtype1 | 67 | 28 | 18 | 7 |
subtype2 | 71 | 27 | 29 | 6 |
subtype3 | 29 | 15 | 15 | 3 |
Figure S119. Get High-res Image Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #9: 'TUMOR.STAGE'
![](D9V9.png)
P value = 0.784 (Fisher's exact test)
Table S129. Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
nPatients | NO | YES |
---|---|---|
ALL | 19 | 302 |
subtype1 | 9 | 116 |
subtype2 | 7 | 126 |
subtype3 | 3 | 60 |
Figure S120. Get High-res Image Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
![](D9V10.png)
P value = 0.533 (ANOVA)
Table S130. Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 223 | 39.9 (26.4) |
subtype1 | 85 | 37.6 (27.4) |
subtype2 | 98 | 42.0 (26.5) |
subtype3 | 40 | 39.5 (24.0) |
Figure S121. Get High-res Image Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
![](D9V11.png)
P value = 0.144 (ANOVA)
Table S131. Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 158 | 1993.5 (13.8) |
subtype1 | 73 | 1991.2 (14.4) |
subtype2 | 61 | 1995.4 (13.2) |
subtype3 | 24 | 1996.0 (12.8) |
Figure S122. Get High-res Image Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
![](D9V12.png)
P value = 0.00543 (Chi-square test)
Table S132. Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
nPatients | CURRENT REFORMED SMOKER FOR < OR = 15 YEARS | CURRENT REFORMED SMOKER FOR > 15 YEARS | CURRENT SMOKER | LIFELONG NON-SMOKER |
---|---|---|---|---|
ALL | 105 | 85 | 71 | 47 |
subtype1 | 40 | 45 | 18 | 15 |
subtype2 | 44 | 29 | 39 | 17 |
subtype3 | 21 | 11 | 14 | 15 |
Figure S123. Get High-res Image Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
![](D9V13.png)
P value = 0.126 (ANOVA)
Table S133. Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 159 | 1964.5 (13.0) |
subtype1 | 64 | 1962.0 (13.5) |
subtype2 | 70 | 1966.5 (13.3) |
subtype3 | 25 | 1965.2 (10.0) |
Figure S124. Get High-res Image Clustering Approach #9: 'MIRseq CNMF subtypes' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
![](D9V14.png)
Table S134. Get Full Table Description of clustering approach #10: 'MIRseq cHierClus subtypes'
Cluster Labels | 1 | 2 | 3 | 4 |
---|---|---|---|---|
Number of samples | 70 | 144 | 40 | 67 |
P value = 0.267 (logrank test)
Table S135. Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #1: 'Time to Death'
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 285 | 80 | 0.0 - 224.0 (10.0) |
subtype1 | 60 | 18 | 0.0 - 83.8 (15.7) |
subtype2 | 130 | 36 | 0.1 - 163.1 (9.9) |
subtype3 | 36 | 5 | 0.4 - 49.0 (9.6) |
subtype4 | 59 | 21 | 0.0 - 224.0 (7.8) |
Figure S125. Get High-res Image Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #1: 'Time to Death'
![](D10V1.png)
P value = 0.233 (ANOVA)
Table S136. Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #2: 'AGE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 291 | 65.3 (9.9) |
subtype1 | 64 | 63.1 (10.5) |
subtype2 | 133 | 66.2 (9.6) |
subtype3 | 37 | 65.6 (10.3) |
subtype4 | 57 | 65.4 (9.7) |
Figure S126. Get High-res Image Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #2: 'AGE'
![](D10V2.png)
P value = 0.0192 (Fisher's exact test)
Table S137. Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #3: 'GENDER'
nPatients | FEMALE | MALE |
---|---|---|
ALL | 177 | 144 |
subtype1 | 28 | 42 |
subtype2 | 81 | 63 |
subtype3 | 27 | 13 |
subtype4 | 41 | 26 |
Figure S127. Get High-res Image Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #3: 'GENDER'
![](D10V3.png)
P value = 0.952 (ANOVA)
Table S138. Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #4: 'KARNOFSKY.PERFORMANCE.SCORE'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 26 | 73.5 (33.3) |
subtype1 | 4 | 82.5 (5.0) |
subtype2 | 12 | 70.8 (35.0) |
subtype3 | 5 | 74.0 (42.2) |
subtype4 | 5 | 72.0 (40.9) |
Figure S128. Get High-res Image Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #4: 'KARNOFSKY.PERFORMANCE.SCORE'
![](D10V4.png)
P value = 0.442 (Chi-square test)
Table S139. Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
nPatients | LUNG ACINAR ADENOCARCINOMA | LUNG ADENOCARCINOMA MIXED SUBTYPE | LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS) | LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS | LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS | LUNG CLEAR CELL ADENOCARCINOMA | LUNG MICROPAPILLARY ADENOCARCINOMA | LUNG MUCINOUS ADENOCARCINOMA | LUNG PAPILLARY ADENOCARCINOMA | LUNG SOLID PATTERN PREDOMINANT ADENOCARCINOMA | MUCINOUS (COLLOID) ADENOCARCINOMA |
---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 10 | 72 | 198 | 3 | 14 | 2 | 2 | 1 | 13 | 1 | 5 |
subtype1 | 1 | 19 | 46 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 |
subtype2 | 5 | 34 | 78 | 2 | 9 | 0 | 2 | 1 | 9 | 0 | 4 |
subtype3 | 2 | 9 | 25 | 0 | 2 | 1 | 0 | 0 | 1 | 0 | 0 |
subtype4 | 2 | 10 | 49 | 1 | 2 | 0 | 0 | 0 | 3 | 0 | 0 |
Figure S129. Get High-res Image Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'
![](D10V5.png)
P value = 0.843 (Chi-square test)
Table S140. Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #6: 'PATHOLOGY.T'
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 91 | 184 | 26 | 17 |
subtype1 | 20 | 41 | 6 | 3 |
subtype2 | 45 | 76 | 11 | 10 |
subtype3 | 10 | 27 | 2 | 1 |
subtype4 | 16 | 40 | 7 | 3 |
Figure S130. Get High-res Image Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #6: 'PATHOLOGY.T'
![](D10V6.png)
P value = 0.129 (Chi-square test)
Table S141. Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #7: 'PATHOLOGY.N'
nPatients | N0 | N1 | N2+N3 |
---|---|---|---|
ALL | 192 | 65 | 54 |
subtype1 | 40 | 13 | 16 |
subtype2 | 86 | 33 | 18 |
subtype3 | 30 | 5 | 4 |
subtype4 | 36 | 14 | 16 |
Figure S131. Get High-res Image Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #7: 'PATHOLOGY.N'
![](D10V7.png)
P value = 0.557 (Chi-square test)
Table S142. Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
nPatients | M0 | M1 | MX |
---|---|---|---|
ALL | 224 | 15 | 74 |
subtype1 | 50 | 3 | 16 |
subtype2 | 95 | 7 | 38 |
subtype3 | 34 | 1 | 5 |
subtype4 | 45 | 4 | 15 |
Figure S132. Get High-res Image Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #8: 'PATHOLOGICSPREAD(M)'
![](D10V8.png)
P value = 0.35 (Chi-square test)
Table S143. Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #9: 'TUMOR.STAGE'
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 167 | 70 | 62 | 16 |
subtype1 | 34 | 16 | 18 | 2 |
subtype2 | 79 | 30 | 21 | 9 |
subtype3 | 25 | 9 | 5 | 1 |
subtype4 | 29 | 15 | 18 | 4 |
Figure S133. Get High-res Image Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #9: 'TUMOR.STAGE'
![](D10V9.png)
P value = 0.829 (Fisher's exact test)
Table S144. Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
nPatients | NO | YES |
---|---|---|
ALL | 19 | 302 |
subtype1 | 5 | 65 |
subtype2 | 7 | 137 |
subtype3 | 3 | 37 |
subtype4 | 4 | 63 |
Figure S134. Get High-res Image Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #10: 'RADIATIONS.RADIATION.REGIMENINDICATION'
![](D10V10.png)
P value = 0.485 (ANOVA)
Table S145. Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 223 | 39.9 (26.4) |
subtype1 | 52 | 43.3 (26.9) |
subtype2 | 96 | 37.3 (24.8) |
subtype3 | 31 | 43.5 (33.2) |
subtype4 | 44 | 38.9 (23.8) |
Figure S135. Get High-res Image Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #11: 'NUMBERPACKYEARSSMOKED'
![](D10V11.png)
P value = 0.0357 (ANOVA)
Table S146. Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 158 | 1993.5 (13.8) |
subtype1 | 26 | 2000.0 (9.6) |
subtype2 | 82 | 1992.1 (14.1) |
subtype3 | 22 | 1995.4 (13.0) |
subtype4 | 28 | 1990.3 (15.4) |
Figure S136. Get High-res Image Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #12: 'STOPPEDSMOKINGYEAR'
![](D10V12.png)
P value = 0.000253 (Chi-square test)
Table S147. Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
nPatients | CURRENT REFORMED SMOKER FOR < OR = 15 YEARS | CURRENT REFORMED SMOKER FOR > 15 YEARS | CURRENT SMOKER | LIFELONG NON-SMOKER |
---|---|---|---|---|
ALL | 105 | 85 | 71 | 47 |
subtype1 | 25 | 8 | 29 | 6 |
subtype2 | 48 | 48 | 21 | 19 |
subtype3 | 13 | 13 | 7 | 6 |
subtype4 | 19 | 16 | 14 | 16 |
Figure S137. Get High-res Image Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #13: 'TOBACCOSMOKINGHISTORYINDICATOR'
![](D10V13.png)
P value = 0.124 (ANOVA)
Table S148. Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 159 | 1964.5 (13.0) |
subtype1 | 39 | 1968.1 (13.8) |
subtype2 | 74 | 1962.2 (12.9) |
subtype3 | 25 | 1966.0 (9.0) |
subtype4 | 21 | 1964.1 (15.0) |
Figure S138. Get High-res Image Clustering Approach #10: 'MIRseq cHierClus subtypes' versus Clinical Feature #14: 'YEAROFTOBACCOSMOKINGONSET'
![](D10V14.png)
-
Cluster data file = LUAD-TP.mergedcluster.txt
-
Clinical data file = LUAD-TP.clin.merged.picked.txt
-
Number of patients = 331
-
Number of clustering approaches = 10
-
Number of selected clinical features = 14
-
Exclude small clusters that include fewer than K patients, K = 3
consensus non-negative matrix factorization clustering approach (Brunet et al. 2004)
Resampling-based clustering method (Monti et al. 2003)
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For continuous numerical clinical features, one-way analysis of variance (Howell 2002) was applied to compare the clinical values between tumor subtypes using 'anova' function in R
For binary clinical features, two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multi-class clinical features (nominal or ordinal), Chi-square tests (Greenwood and Nikulin 1996) were used to estimate the P values using the 'chisq.test' function in R
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.